1. RADT-16. CLINICAL OUTCOMES FOR HIGH RISK WHO GRADE II GLIOMA PATIENTS TREATED WITH UPFRONT TMZ-BASED CHEMORADIOTHERAPY. (14th November 2022) Authors: Zarabi, Hosniya; Wicks, Robert; Russel, Gregory; Banderage, Dineth; Strowd, Roy; Mott, Ryan; Laxton, Adrian; Tatter, Stephen; White, Jaclyn; Lo, Hui-Wen; Debinski, Waldemar; Chan, Michael; Lesser, Glenn; Cramer, Christina Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗